Page 13 - Prescription Prices News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Steven Ferdman/Getty Images This story is available exclusively to Insider subscribers. Become an Insider and start reading now. Mark Cuban s new drug company has plans to slash drug prices by 90% or more. Its CEO Dr. Alex Oshmyansky has been trying to do so for years, raising $1.3 million at Y Combinator in 2018. It intends to cut high drug costs through transparent pricing and a new Dallas manufacturing facility that will finish packaging drugs for patient distribution. Before launching with Y Combinator in 2018, Dallas radiologist Dr. Alex Oshymansky had been trying to lower the cost of generic drugs for years. Under the name Osh s Affordable Pharmaceuticals, he set out in 2015 to manufacture low-cost rare disease drugs whose prices had shot up by 400 times or more. 

United statesBaylor college of medicineMartin shkreliAlex oshymanskyMark cubanRojelio mejiaAlex oshmyanskyOsh affordable pharmaceuticalsMark cuban cost plus drug companyAffordable pharmaceuticalsMark cuban cost plusBaylor collegeDallas businessBig pharmaCuban cost plusPrescription drugs